Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Evaluación multicéntrica de la recuperación mejorada después del protocolo de cirugía en cirugía de escoliosis idiopática adolescentes (EMRACSIA)

23 de septiembre de 2026 actualizado por: Hospices Civils de Lyon

Adolescent idiopathic scoliosis is a deformation of the spine affecting 2 to 4% of under 18 years old population. This can have severe physical or psychological impact during adulthood. The deformation causes mechanical constraints resulting in early osteoarthritis, which results in adulthood disability.

There is also an impact on the respiratory function in most severe cases of idiopathic scoliosis. Adolescents affected by a scoliosis with an angle of 40° of more undergo a surgery called posterior fusion during adolescence to limit these impacts.

In France, more than 1000 adolescent patients undergo a surgery called posterior spinal fusion for their severe scoliosis.

This aims to straighten the spine by bone grafting all the vertebras included in the scoliosis. Two metal rods are implanted to favour osteosynthesis of the straight spine.

This intervention suffer of a bad image and worries the patients and their parents, as it needs metal implants near the spinal cord.

The worry comes from the most severe complication that may happen exceptionally following this surgery, which is a definitive paraplegia. The scar is quite large and the surgery reduces the mobility of a part of the spine. The intervention produces a quite large haemorrhage, which leads to a diminution in haemoglobin level, resulting in a fatigue during the following weeks.

On the following days, the patient will need a specific protocol of pain management including morphine-based and anti-inflammatory drugs.

This intervention will often require a 5 to 7 days hospitalization with a 1 to 2 month convalescence period at home or in rehabilitation centre.

This intervention is performed on adolescent patients without comorbidities. Moreover, the surgical approach is not profound passing between the para-vertebral muscles with no close large blood vessels or major organs. The pain is caused by correction tensions and the access to the vertebras during the surgery.

Surgical techniques have considerably evolved allowing shorter interventions and to reduce the loss of blood.

The association between morphine-based treatments and grade I analgesics enables an effective pain management.

This intervention appears to perfectly suit to an enhanced recovery after surgery procedure (ERAS).

ERAS is a set of procedure meant to enhance its tolerance and to reduce its morbidity and the hospitalization duration after surgery and the recovery duration.

ERAS is well developed in adult patients undergoing surgery, it is also well described in paediatric patient especially on adolescent scoliosis surgeries.

As the pain is well controlled during the hospitalization as well when the patient get back home, there are very few obstacles to an ERAS procedure in this indication for a patient without comorbidities.

Numerous articles report experiences of medical staff with ERAS protocols.

Generally, the set of measures includes:

  • Before surgery: Providing information and therapeutic patient education, iron supplementation, physiotherapy, skin disinfection, digestive preparation against constipation
  • During surgery: recuperations of blood cells to limit blood loss, use of modern tools to facilitate the positioning of pedicle screws, surgery performed by 2 surgeons
  • After surgery: Pain management until stopping of analgesics by patient and maintenance of a link between the patient at home and the hospital staff after end of hospitalization The articles published about ERAS reports a favourable experience of such protocols with an efficient pain management, reduced hospitalization durations without increasing morbidity or re-hospitalizations. However, no studies have studied and proved by a robust scientific method the benefits of ERAS in adolescent scoliosis.

No studies evaluate the patients' quality of life or follow the patient for more than 6 months after surgery (limiting the assessment of long term complications e.g. infectious complications).

The link between hospital staff and the patient after his return back home is not described as well.

This research project aims to confirm with a robust scientific approach that ERAS protocols in idiopathic scoliosis in adolescents allow to reduce the duration of hospitalization compared to standard of care procedures while improving quality of life after surgery.

Descripción general del estudio

Tipo de estudio

Intervencionista

Inscripción (Estimado)

316

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Copia de seguridad de contactos de estudio

Ubicaciones de estudio

      • Amiens, Francia, 80054
        • Reclutamiento
        • CHU d'Amiens Site Sud
        • Contacto:
        • Investigador principal:
          • Richard GOURON, MD
      • Besançon, Francia, 25000
        • Reclutamiento
        • CHU de Besançon Hopital Jean Minjoz
        • Contacto:
        • Investigador principal:
          • Jeremie NALLET, MD
      • Bron, Francia, 69677
        • Reclutamiento
        • Pediatric orthopedic surgery unit Hôpital femme Mère Enfant (HFME)
        • Contacto:
        • Investigador principal:
          • Vincent CUNIN, MD
      • La Tronche, Francia, 38700
        • Reclutamiento
        • CHU de Grenoble Hôpital Couple Enfant
        • Contacto:
        • Investigador principal:
          • Aurélien COURVOISIER, MD
      • Lyon, Francia, 69322
        • Reclutamiento
        • Centre Medico-Chirurgical de Réadaptation des Massues Croix-Rouge
        • Investigador principal:
          • Kariman ABELIN-GENEVOIS, MD
        • Contacto:
      • Marseille, Francia, 13005
        • Reclutamiento
        • AP-HM Hôpital de la Timone
        • Contacto:
          • Sebastien PESENTI, MD
          • Número de teléfono: +33 04 91 38 86 56
          • Correo electrónico: Seb.pesenti@gmail.com
        • Investigador principal:
          • Sebastien PESENTI, MD
      • Nice, Francia, 06200
        • Reclutamiento
        • Fondation LENVAL
        • Contacto:
        • Investigador principal:
          • Frederico SOLLA, MD
      • Saint-Priest-en-Jarez, Francia, 42270
        • Reclutamiento
        • CHU de Saint-Etienne Hôpital Nord
        • Contacto:
        • Investigador principal:
          • Elie HADDAD, MD
      • Toulouse, Francia, 31059
        • Reclutamiento
        • CHU de Toulouse
        • Contacto:
        • Investigador principal:
          • Tristan LANGLAIS, MD
      • Toulouse, Francia, 31100
        • Reclutamiento
        • Clinique Médipôle Garonne
        • Contacto:
        • Investigador principal:
          • Roxane COMPAGNON, MD
      • Trélazé, Francia, 49800
        • Reclutamiento
        • Clinique St Leonard
        • Contacto:
        • Investigador principal:
          • Audrey ANGELLIAUME, MD

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

11 años a 17 años (Niño)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Adolescents between 11 and 17 years old
  • Adolescent idiopathic scoliosis diagnosis
  • Posterior vertebral fusion surgery indicated to treat the patient
  • Informed consent signed by both parents / legal guardians

Exclusion Criteria:

  • Comorbidities that might influence the duration of hospitalization (e.g. respiratory failure, diabetes…)
  • Previous spine surgery
  • Patient not benefiting from an health insurance plan
  • Pregnant, parturient or breastfeeding woman
  • Patient benefiting of psychiatric care
  • Patient subject to a legal protection measure (guardianship, curatorship)

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Cuidados de apoyo
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Experimental group : Improved Recovery After Surgery

Patients in this group will undergo vertebral posterior fusion surgery with the Enhanced recovery after surgery protocol.

This will include at least:

  • A one-day hospitalization to visit the surgical unit and to provide therapeutic education to patients and their parents.
  • A transition to morphine based treatments per os from intravenous morphine on the second day following surgery
  • Phone calls from a surgery unit nurse 2 times a day during 5 days
  • A teleconsultation with the surgeon between D3 and D5 following surgery Patients will also have a first consultation with the anesthesist and the surgeon then the surgery will be planned.

They will also have 2 appointments at the hospital for post-surgical follow-up at D45 and M12.

This will include at least:

  • A one-day hospitalization to visit the surgical unit and to provide therapeutic education to patients and their parents.
  • A transition to morphine based treatments per os from intravenous morphine on the second day following surgery
  • Phone calls from a surgery unit nurse 2 times a day during 5 days
  • A teleconsultation with the surgeon between D3 and D5 following surgery
Experimental: Control group

Patients in this group will undergo posterior vertebral fusion surgery without the set of procedures for ERAS.

They will have a first consultation with the anesthesist and the surgeon then the surgery will be planned. The discharge from hospital after surgery will not happen early and the standard of care procedures will be followed during and after surgery.

Patients will receive 2 phone calls at D1 and D5 after surgery. The patient will also have 2 appointments at the hospital for post-surgical follow-up at D45 and M12.

Patients in this group will undergo posterior vertebral fusion surgery without the set of procedures for ERAS.

They will have a first consultation with the anesthesist and the surgeon then the surgery will be planned. The discharge from hospital after surgery will not happen early and the standard of care procedures will be followed during and after surgery.

Patients will receive 2 phone calls at D1 and D5 after surgery. The patient will also have 2 appointments at the hospital for post-surgical follow-up at D45 and M12.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Demonstrate that ERAS in adolescent idiopathic scoliosis compared to standard of care procedure
Periodo de tiempo: At Month 3 (Collected on the day of discharge from surgery hospitalization)

Hospitalization duration measured in days

At Month 3 (Collected on the day of discharge from surgery hospitalization)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Improvement of quality of life at one day after return at home
Periodo de tiempo: Day 1 (VT1) after discharge from surgery hospitalization

Quality of life questionnaires (PedsQL) at day 1 after return at home 4-point scale : 0 if it's never a problem

  1. if it's almost never a problem
  2. if it's sometimes a problem
  3. if it's often a problem
  4. if it's almost always a problem
Day 1 (VT1) after discharge from surgery hospitalization
Improvement of quality of life at 5 days, 45 days and 12 months after return at home
Periodo de tiempo: Day 1 (VT1), day 45 (V4) and month 12 (V5) after discharge from surgery hospitalization

Quality of life questionnaires (PedsQL) at day 5, day 45 and month 12 after return at home 4-point scale : 0 if it's never a problem

  1. if it's almost never a problem
  2. if it's sometimes a problem
  3. if it's often a problem
  4. if it's almost always a problem
Day 1 (VT1), day 45 (V4) and month 12 (V5) after discharge from surgery hospitalization
Changing post-surgical pain during hospitalization
Periodo de tiempo: Day 0 (V3), day 1 (VT1), day 5 (VT3); day 45 (V4) and month 12 (V5) after discharge from surgery hospitalization]

Visual analog pain scale during surgery hospitalization 10-point scale: 0: no pain 10: uncontrollable pain

Day 0 (V3), day 1 (VT1), day 5 (VT3); day 45 (V4) and month 12 (V5) after discharge from surgery hospitalization]
Changing post-surgical pain at day 1, day 5, day 45 and month 12 after return at home
Periodo de tiempo: Day 1 (VT1), day 5 (VT1), day 45 (V4) and month 12 (V5) after discharge from surgery hospitalization

Visual analog pain scale 10-point scale: 0: no pain 10: uncontrollable pain

Day 1 (VT1), day 5 (VT1), day 45 (V4) and month 12 (V5) after discharge from surgery hospitalization
Changing post-surgical complications at day 45 and month 12
Periodo de tiempo: Day 45 (V4) and month 12 (V5)

Complications after surgery at day 45 and month 12 10-point scale: 0: no pain 10: uncontrollable pain

Day 45 (V4) and month 12 (V5)
Changing the rate of re-hospitalization during the 12 months following surgery
Periodo de tiempo: From day of surgery day 0 (V3) to month 12 (V5)

Re-hospitalization rate during the 12 monts following surgery

From day of surgery day 0 (V3) to month 12 (V5)
Describe the acceptability of the early discharge date from hospitalization in the two arms by patients and their parents
Periodo de tiempo: Day of surgery day 0 (V3)

Percentage of parents refusal for early discharge date

Day of surgery day 0 (V3)

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

21 de septiembre de 2026

Finalización primaria (Estimado)

21 de agosto de 2030

Finalización del estudio (Estimado)

21 de agosto de 2030

Fechas de registro del estudio

Enviado por primera vez

7 de marzo de 2025

Primero enviado que cumplió con los criterios de control de calidad

26 de marzo de 2025

Publicado por primera vez (Actual)

3 de abril de 2025

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

24 de septiembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

23 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir